- Home
- GDEV vs IMRX Comparison
GDEV vs IMRX Comparison
Compare GDEV & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEV | IMRX |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | Cyprus | United States |
| Employees | 475 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.1M | 265.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GDEV | IMRX |
|---|---|---|
| Price | $12.14 | $5.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.20 |
| AVG Volume (30 Days) | 1.6K | ★ 1.6M |
| Earning Date | 05-15-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.75 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.56 | N/A |
| Revenue Next Year | $8.05 | N/A |
| P/E Ratio | $5.19 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.20 | $2.90 |
| 52 Week High | $42.20 | $10.08 |
Technical Indicators
Market Signals| Indicator | GDEV | IMRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.27 | 61.89 |
| Support Level | $11.54 | $4.82 |
| Resistance Level | $13.93 | $5.36 |
| Average True Range (ATR) | 0.52 | 0.28 |
| MACD | 0.06 | 0.13 |
| Stochastic Oscillator | 34.44 | 94.92 |
Price Performance
Historical ComparisonAbout GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.